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PreviewsPrecious metal economy
The zebrafish is emerging as a system of choice for modeling human disease. In this issue of Cell Metabolism, Mendelsohn
et al. (2006) describe a model for Menkes disease, a genetic disorder in copper utilization. Using genetic and chemical
screens, the authors highlight the impact of maternal nutrition on embryo development. The work reveals a hierarchy of
temporal and dosage-dependent phenotypes for copper nutrition.In the last two decades, we have learned
that metabolism of trace elements—for
example, copper, iron, manganese, sele-
nium and zinc—is tightly regulated. This
is necessary because the chemical prop-
erties that render these elements so
useful in biology are also the properties
responsible for their toxicity. Organisms
therefore maintain homeostasis in re-
sponse to variation in nutritional supply
and demand for each metal cofactor in
individual cells depending on their metal-
loenzyme content. The metal handling
processes that operate in individual cells
include catalysis of metal nutrient uptake
(or efflux) by selective and high-affinity
transporters, catalysis of distribution or
intracellular trafficking via metallocha-
perones and distributive transporters,
and storage in an inert form or location.
Regulation of these processes is dynam-
ically responsive to supply and demand
and is generally multilayered, even in uni-
cellular microorganisms.
In multicellular organisms, these path-
ways operate in the context of different
cell types, tissues, and organs whose
macromolecular compositions and met-
abolic functions are unique. This means
that demand for and utilization of an es-
sential metal cofactor nutrient is cell spe-
cific, which adds a layer of complexity
to the understanding of trace-metal ho-
meostasis mechanisms. In the case of
copper nutrition and Menkes disease,
a genetic disorder in copper utilization
that results in severe developmental ab-
normalities and lethality, physicians have
long realized that various degrees of
copper deficiency differentially alter the
known biomarkers of copper status, re-
vealing a hierarchy of copper utilization
in humans (Turnlund, 1998), but the un-
derlying mechanisms are not understood.
The evolutionary conservation in copper
homeostasis pathways suggests that
discovery in model organisms can guide
copper replacement therapies in humans.
Recent studies (Wingert et al., 2005;
Mendelsohn et al., 2006) underscore
the enormous potential of the zebrafishCELL METABOLISM 4, 99–105, AUGUST 2006model for understanding certain human
metabolic diseases related to metal
homeostasis. By analyzing a zebrafish
mutant in a glutaredoxin isoform, shiraz,
Wingert et al. previously uncovered a
tight metabolic connection between
two major iron-utilizing pathways—Fe-S
cluster and haem biosynthesis. In this
issue of Cell Metabolism, Mendelsohn
et al. describe chemical and genetic ze-
brafish models that recapitulate many
of the phenotypic features of Menkes
disease. The two complementary ap-
proaches employed in the Mendelsohn
et al. study nicely illustrate the technical
possibilities offered by model organisms
for studies of developmental disorders.
The model also suggests experimental
approaches to therapeutic discoveries.
The authors first describe a small-
molecule screen that identified chemi-
cals causing phenotypes of copper
deficiency. This sort of chemical genetic
screen is most popular in simple organ-
isms, such as yeast, but the accessibility
of zebrafish embryos, which are fertilized
and develop externally, also makes them
well suited to this approach (Peterson
et al., 2000). With this method, Mendel-
sohn et al. discovered several copper-
chelating chemicals that cause identical
developmental syndromes. Embryos ex-
posed to these copper-depleting chemi-
cals exhibit defects in the development
of the notochord, vascular system, blood,
cartilage, central nervous system, and
pigment cells. Because zebrafish em-
bryos develop in water, chemicals can
be added or washed out at precise
stages, making it possible to dissect their
temporal and dosage requirements. In
this way, Mendelsohn et al. made the
surprising observation that very brief ex-
posure early in development to copper-
chelating agents was sufficient to cause
defects much later. This suggests that
embryos are unable to acquire copper
at its typical low concentration in the ex-
ternal environment during development
and that brief exposure to chelating
agents is sufficient to make a criticalª2006 ELSEVIER INC.proportion of the maternally deposited
copper pool permanently unavailable. In
an earlier study, Wingert et al. (Wingert
et al., 2004) developed a method of iron
supply (by injection) at the one-cell stage
to distinguish between iron metabolism
defects in assimilation versus metabo-
lism and distribution. Their method, if
broadly applied, could provide interest-
ing insights into maternal contribution
to micronutrient requirement and the ac-
quisition of assimilatory transport capac-
ity in the context of the developing
embryo.
A general disadvantage of chemical
genetic screens is that it can be difficult
to identify in vivo targets of small mole-
cules. Classical mutagenesis screens, on
the other hand, make possible the iden-
tification of specific genes involved in a
biological process. The work in the Men-
delsohn et al. (2006) paper provides an
excellent example of the convergence of
these two complementary approaches.
Mendelsohn et al. performed a genetic
screen that identified the mutant calamity
(cal), which exhibits a constellation of
defects strikingly similar to embryos de-
pleted of copper by chemical methods.
Satisfyingly, the authors find that the cal
phenotype is caused by a mutation in
the zebrafish atp7a gene, the ortholog of
the human copper transporter that is
defective in Menkes disease (Mercer,
2001). Indeed, the human cDNA effec-
tively rescues cal, which opens the door
to in vivo structure-function studies of
ATP7A. A range of allelic mutations at
the humanMNK locus can now be readily
analyzed by detailed phenotypic char-
acterization in a developmental context.
Another experiment made possible by
the zebrafish mutant model is the crea-
tion of cellular chimeras by cell transplan-
tation. By analyzing chimeric embryos
with wild-type and cal mutant cells, the
authors were able to demonstrate that
copper deficiency is a cell-autonomous
defect in pigment cells.
The Mendelsohn et al. (2006) study
also dramatizes the interplay of nutrition99
P R E V I E W SFigure 1. A gradient of copper deficiency results in progressive developmental phenotypes
Treatment of embryos with copper chelators reduces copper availability for the biosynthesis of copper en-
zymes in each cell. A gradient of deficiency (triangle) can be created by increasing either the time of treatment
or the concentration of the chelator (neocuproine). The phenotypes range from mild to severe and result from
loss of specific cuproenzyme function in various cells.and genetics in determining normal em-
bryo development. Phenotypically normal
heterozygous cal embryos or embryos
injected with small (non-phenotype-
causing) doses of atp7a morpholinos
are much more sensitive to treatment
with copper chelators than wild-type
embryos are. This observation, taken to-
gether with the cell-autonomous function
of ATP7A, suggests that genetic factors
that modify the tissue-specific expres-
sion or function of ATP7A may be iden-
tified by screening for a subset of cal
phenotypes resulting from short-term or
low-dose copper chelator treatment.
A new interest in trace-metal homeo-
stasis is the impact of marginal defi-
ciency, which is a common nutritional
problem even in affluent populations in
industrialized nations. With so many dif-
ferent metalloenzymes in a cell present
at stoichiometries that range over orders
of magnitude, and in different subcellular
compartments, how is allocation of cop-
per or iron or zinc to individual enzymes
determined? One solution is that thermo-
dynamics determines distribution—that
is, the metals end up on proteins with
the tightest binding site. But this view
runs counter to the fundamental princi-
ples of biochemical metabolism, where
regulation of catalyzed reactions effects100exquisite metabolic homeostasis. Micro-
organisms do prioritize intracellular cop-
per and iron distribution in a nutrient-
limiting situation by sacrificing some
proteins to spare the catalytic metal for
maintaining the function of another,
perhaps more critical, enzyme (reviewed
in Kaplan et al., 2006; Merchant et al.,
2006).
In the Mendelsohn et al. (2006) study,
sequential loss of copper enzymes is
observed as a function of time and dose
of small-molecule treatment: Very short
treatments resulted in absence of mela-
nin, longer treatments affected the no-
tochord, and still longer treatments re-
capitulated the entire copper-deficiency
syndrome (Figure 1). Does this reflect
prioritized distribution between cells de-
pending on the biochemical importance
of individual copper proteins in various
tissues/organs? Or does it simply reflect
the sequence in which these tissues/cells
run out of their maternal endowment?
The former possibility is exemplified by
the situation in microorganisms, whereas
an example of the latter possibility is pro-
vided by the varied phenotypes of loss-
of-function alleles of the zebrafish mutant
foggy, where specific defects in the brain
and heart are evident when maternal
supplies of a transcriptional elongationfactor (presumably required in all cells)
fall below a critical level (Guo et al.,
2000; Keegan et al., 2002; Cooper
et al., 2005). The new techniques used
for studying metal metabolism in zebra-
fish should distinguish the two models
and illuminate the underlying operational
mechanisms.
Zebrafish embryos may be useful
models for understanding the etiology of
metal-homeostasis disease and possi-
bly even for developing treatments. For
example, another small-molecule screen
could be used to discover chemicals that
might mitigate the effects of copper defi-
ciency in the chemical or genetic model,
thus identifying potential treatments for
Menkes disease or another copper-utili-
zation disorder, Wilson’s disease (Mer-
cer, 2001). Conversely, a genetic strat-
egy—finding suppressors or enhancers
of the cal mutant—could identify other
components of the copper transport or
utilization pathways that may also be
targets for therapeutics or diagnosis.
The Mendelsohn et al. (2006) contribu-
tion is one of several in recent years to
demonstrate that genetic defects in the
zebrafish model can closely mimic hu-
man disease states. The challenge for
the field is now to demonstrate the use-
fulness of the models not only for new
fundamental discoveries in cell biology
and development but also for developing
therapeutics and understanding disease
etiologies.
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Although it has long been hypothesized
evidence has been scarce so far. A new s
variability in gene expression in aging m
oxidative stress (Bahar et al., 2006).
Regulated gene expression is critical to
maintaining the differentiated state and
to controlling cell death, cell division,
and the transition to cancer. Gene ex-
pression in aging cells exhibits a number
of characteristic changes, including the
tissue-specific induction of oxidative
stress-response genes (Balaban et al.,
2005). Other changes in gene expression
during aging may reflect a loss of gene
regulation and a failure to maintain the
differentiated state, such as the misex-
pression of extracellular matrix-degrad-
ing enzymes in senescent fibroblasts
(Campisi, 2005). A new study (Bahar
et al., 2006) demonstrates that aging
can be also be associated with in-
creased variability in gene expression,
a finding that might ultimately shed light
on the variability inherent in aging and
life span.
Past analyses of gene expression in
aging flies failed to find evidence of in-
creased variability (Rogina et al., 1998).
However, these studies were limited by
the available methods for quantifying
gene expression and the inability to as-
say individual cells. In the present paper
(Bahar et al., 2006), the authors use
PCR to measure gene expression in
individual cells dissected from young
and old mouse hearts. Their seminal
observation is that cell-to-cell variability
in gene expression increases during
aging. In other words, for a given gene,
in some cells expression is increased
while in others expression is decreased.
This was observed for a variety of
nuclear genes, but notably not for mito-
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ley, K., Fraenkel, P., Axe, J.L., Davidson, A.J.,oken heartstrings
that gene expression might become more
tudy reports detection, by PCR analysis of
ouse heart; moreover, a similar variability c
chondrial genes. A similar cell-to-cell
variability in gene expression could be
generated in cultured fibroblasts by
treatment with H2O2, suggesting an ap-
pealing model in which oxidative stress
leads to DNA damage that in turn some-
how leads to increased variability in gene
expression.
A loss of genome integrity is critically
implicated in processes associated with
aging, including replicative senescence
and cancer (Campisi, 2005). DNA dam-
age (which includes single- and double-
strand breaks and missing or modified
bases) has a variety of causes. Reactive
oxygen species may be particularly im-
portant, especially in metabolically active
tissues such as heart muscle. Different
types of mutation can result, including
point mutations, deletions, duplications,
chromosomal inversions, and transloca-
tions. Because somatic tissues such
as heart muscle and fibroblasts rely pri-
marily on nonhomologous end-joining
(NHEJ) (as opposed to homologous re-
combination) for DNA repair, there is
ample opportunity for rearrangements
and loss of information (Karanjawala
and Lieber, 2004). Vijg and coworkers
found that the changes in the DNA of ag-
ing heart cells include many large chro-
mosomal rearrangements (Bahar et al.,
2006). Indeed, duplications and deletions
which alter gene copy number would
be predicted to result in increased ex-
pression in some cells and decreased
expression in others, assuming a lack
of tight feedback regulation. Moreover,
even in the absence of an actual geneBarut, B., Noriega, L., Sheng, X., et al. (2004).
Development 131, 6225–6235.
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individual cells, of increased cell-to-cell
an be generated in cultured cells using
duplication or deletion, chromosomal
rearrangements can have far-reaching
effects on gene expression.
The importance of the three-dimen-
sional architecture of the interior of the
nucleus in regulating gene expression
has become increasingly apparent (Fig-
ure 1). According to current models,
each chromosome is organized into dis-
crete and tissue-specific domains of
transcriptional activity and DNA replica-
tion timing involving unique chromatin
structures and covalent modifications of
the DNA (Kuhn and Geyer, 2003; MacAl-
pine and Bell, 2005; Noma et al., 2006).
Transcriptional enhancers and locus con-
trol regions a few hundred base-pairs in
size can coordinately regulate the expres-
sion of multiple genes distributed through-
out a region of thousands of kb, in part by
recruitment of enzymes that rearrange
and/or covalently modify protein or DNA.
‘‘Insulator’’ or ‘‘barrier’’ DNA elements
can block an activating signal from an
enhancer or block the propagation or
‘‘spread’’ of repressive chromatin struc-
tures such as heterochromatin along
the length of the chromosome. Several
of the chromosomal regulatory elements
have been found to associate with the
nuclear substructure and arrange the
chromosome string into loop-like do-
mains (Kuhn and Geyer, 2003; Noma
et al., 2006). In yeast, insulator and
barrier elements have been shown to
functionally associate with specific mac-
romolecular complexes in the nuclear
periphery, including the nuclear pores.
These elements appear to tether specific
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